Esnofil 150mg Tablet

Introduction

Esnofil is a prescription medication that contains the active ingredient Diethylcarbamazine. It is available under the brand name Esnofil. This medication is primarily used for the treatment of certain parasitic infections.

Uses

Esnofil is prescribed to treat various conditions caused by parasitic worms, including lymphatic filariasis, a disease that affects the lymphatic system. It is also used to manage other infections caused by certain types of worms.

Dosage and Administration

The dosage and administration of Esnofil should be determined by a healthcare professional based on the specific condition being treated. Follow their instructions carefully and not exceed the recommended dosage.

The tablets are usually taken orally with water. It is advisable to take the medication with food to minimize stomach upset. Crushing or chewing the tablets should be avoided, as this may affect the medication’s effectiveness.

Mechanism of Action

Esnofil works by interfering with the growth and reproduction of parasitic worms. It helps to immobilize and kill the worms, allowing the body’s natural defenses to eliminate them. This helps to alleviate the symptoms and resolve the underlying infection.

Side Effects

Common side effects may include nausea, vomiting, dizziness, headache, and abdominal pain. These side effects are usually mild and temporary, but if they persist or worsen, consult a healthcare professional.

In rare cases, serious side effects such as allergic reactions, skin rash, difficulty breathing, or swelling of the face, lips, tongue, or throat may occur. If any of these serious side effects occur, medical attention should be sought immediately.

Drug Interactions

Esnofil may interact with certain medications, including those used to treat epilepsy, heart conditions, and psychiatric disorders. Inform your healthcare professional about all the medications, supplements, and herbal products you are taking before starting Esnofil.

Interactions with other medications can affect the effectiveness of Esnofil or increase the risk of side effects. Your healthcare professional will be able to guide you on the appropriate use of this medication in combination with other drugs.

Precautions

Before taking Esnofil, inform your healthcare professional about any existing medical conditions, especially if you have a history of liver or kidney problems, epilepsy, or any allergies.

This medication should not be used in individuals who have a known hypersensitivity to Diethylcarbamazine or any of the other ingredients in the tablet. Follow your healthcare professional’s advice and not take this medication if you have any contraindications.

Storage

Patient Tips

• Take Esnofil exactly as prescribed by your healthcare professional. Do not skip doses or stop the medication without their guidance.
• If you experience any bothersome side effects, consult your healthcare professional. They may be able to provide recommendations or adjust the dosage if necessary.
• complete the full course of treatment as prescribed, even if you start feeling better before the treatment is complete.
• If you have any concerns or questions about Esnofil, do not hesitate to reach out to your healthcare professional for clarification.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Diethylcarbamazine Advanced Patient Information Consumer Information (Micromedex) (Drugs.com) [Accessed 24 Jun. 2024] (online) Available at:
• About Lymphatic Filariasis (Centers for Disease Control and Prevention) [Accessed 0 Jun. 2024] (online) Available at:
• Maizels RM, Denham DA. Diethylcarbamazine (DEC): immunopharmacological interactions of an anti-filarial drug. Parasitology. 1992;105 Suppl:S49-60. doi: 10.1017/s0031182000075351. [Accessed 0 Jun. 2024] Available at:
• Williams PDE, Kashyap SS, Robertson AP, Martin RJ. Diethylcarbamazine elicits Ca(2+) signals through TRP-2 channels that are potentiated by emodepside in Brugia malayi muscles. Antimicrob Agents Chemother. 2023 Oct 18;67(10):e0041923. doi: 10.1128/aac.00419-23. Epub 2023 Sep 20. [Accessed 12 Jun. 2024] Available at: